Rheinmetall's Order Book Meets Its Execution Test: Belgium Adds Skyranger as Brokers Split on €900

Rheinmetall shares changed hands at €770.80 in pre-market trading, a price that captures a debate now running through the entire European defence sector. The question is no longer whether demand exists — the order backlog answers that — but whether the company can convert it into revenue on schedule.

Belgium provided fresh evidence of that demand on Monday, ordering Skyranger 30 systems along with logistics support, with deliveries slated to begin at the end of 2028. The contract strengthens the medium-term picture. It does nothing, however, for the nearer-term test, which remains the execution of business already on the books.

A Guidance Cut That Reframed the Debate

Rheinmetall trimmed its 2026 revenue forecast last week to roughly €13.2bn, down from a prior range of €13.7–14.2bn. The expected operating margin was also lowered to around 18.5%, from approximately 19%. Management attributed both revisions to delays on the Bundeswehr's Arminius project and to the acceptance of artillery ammunition.

The timing of the cut matters. It came in early November, and it gave sector-wide scepticism a company-specific anchor. When Czech defence group CSG warned about its own margin targets, the read-across to Rheinmetall found a receptive audience. Shares fell 4.0% on the day, dragged down by the wider defence sector, with media reports also pointing to peace talks in Abu Dhabi as a factor weighing on sentiment.

Should investors sell immediately? Or is it worth buying Rheinmetall?

Two Brokers, Two Readings of the Same Slide

SRH AlsterResearch pushed back. The research house reiterated its buy rating and its €1,050 price target, arguing that the transfer of CSG's share-price slump onto Rheinmetall was unjustified.

Berenberg took the other side of the argument on Tuesday, cutting its target to €900 from €1,020 while keeping a "Hold" rating. The broker cited execution risks and the predictability of demand.

The two calls frame the range of opinion neatly. One camp argues the market is over-applying a competitor's problems to Rheinmetall. The other questions how reliably the company can plan its own business. Both converge on the same operational proving ground.

Growth Is Not in Doubt — Its Timing Is

The underlying numbers give the bulls plenty to work with. Revenue for the first nine months of 2026 reached €8.4bn, up 38%. Operating result came in at €1.339bn, a jump of 69% year on year, at an operating margin of 16.0%.

The order backlog stood at €78.0bn after the first nine months — the single strongest argument for a constructive view. What determines its value to shareholders is how reliably the company works through those orders.

That is where the guidance cut bites. Revenue contributions are shifting into the following year, according to the company. For investors, the durability of the plan becomes the central issue. The prospect of later revenue supports the case, provided the deferred contributions actually materialise as expected.

What Would Break the Recovery Case

Continued delays are the serious counterargument. Arminius and the ammunition acceptance issues have already weighed on the annual plan. If such problems persist, even a substantial backlog could only partly offset uncertainty over when results will land.

Rheinmetall at a turning point? This analysis reveals what investors need to know now.

A further slippage would be especially damaging if it hit revenue recognition and earnings at the same time. Any more favourable valuation would then have to rest on later business success, raising the bar on how credible the plan looks.

Investors are therefore weighing the quality of growth as much as its pace. The more comfortable scenario requires Rheinmetall to pair strong demand with more predictable deliveries and acceptances. Only then can the existing business base be translated more convincingly into expectations for future earnings.

The Capital Markets Day Is the Next Marker

The announced Capital Markets Day on 26 and 27 November 2026 is the next concrete date on the calendar. What matters for investors is whether the presentations there make the link between backlog, timing and earnings easier to follow. On that hinges whether the business base once again outweighs the execution risk.

As long as Rheinmetall meets its revised plan and the named delays stay contained, the recovery scenario has an operational foundation. Should the reliability of execution falter, the lofty backlog would lose much of its power as an argument for a re-rating.

Ad

Rheinmetall Stock: New Analysis - 13 November

Fresh Rheinmetall information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rheinmetall analysis...